Evidence map›Paper›PMID 19071972›Full record

ReviewPsychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors2008

Over-the-counter nicotine replacement therapy: can its impact on smoking cessation be enhanced?

Nancy Amodei, R J Lamb

Abstract readReview
In one paragraph

Review in Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. The role of nicotine replacement therapy in early quitting success.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2010
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Pharmacologic agents for smoking cessation: a clinical review.Clinical pharmacology : advances and applications · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nancy AmodeiDepartment of Pediatrics, University of Texas Health Science Center at San Antonio, USA. Amodei@uthscsa.edu
R J Lamb
The University of Texas Health Science Center at San Antonio · US

Funding

INCREASING CONTINGENCY MANAGEMENT SUCCESS USING SHAPINGR01DA013304 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LAMB, RICHARD J · 1999 to 2009
$3.3M
NIDA NIH HHS R01 DA013304
6 · The paper itself

Abstract

Nicotine replacement therapies (NRTs) are efficacious smoking-cessation aids. However, only minimal increases in smoking cessation followed NRTs being made available over-the-counter (OTC), which presumably made these treatments more readily available. To better understand why the United States did not experience improvements in smoking cessation following the OTC availability of NRTs, it is useful to review factors that determine NRT's impact on smoking cessation and how these factors played out with the introduction of OTC NRT. The authors contend that for NRTs to have a greater impact on public health, increases are needed in the number of individuals making a quit attempt, the proportion using NRTs in a quit attempt, and the effectiveness of each quit attempt. Even small increases in the impact of OTC NRTs could yield significant benefits in terms of morbidity and mortality. The remainder of this article provides examples of interventions designed to target each of the aforementioned factors individually as well as examples of interventions that link increased cessation attempts, increased NRT reach, and increased NRT efficacy in order to synergistically enhance the impact of OTC NRTs.

Indexed as

Nonprescription DrugsAttitude to HealthCross-Sectional StudiesCultureHumansNicotineSelf AdministrationSmoking CessationTobacco Use DisorderTreatment OutcomeNicotineNonprescription Drugs

Identifiers

PMID19071972
PMCPMC3577424
OpenAlexW2084467916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.